Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

14.00
Delayed Data
As of Aug 18
 -0.35 / -2.44%
Today’s Change
13.41
Today|||52-Week Range
19.62
+1.23%
Year-to-Date
No recent news for Lexicon Pharmaceuticals Inc.

Today’s Trading

Previous close14.35
Today’s open14.26
Day’s range13.89 - 14.29
Volume555,659
Average volume (3 months)724,386
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-5.30%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book9.27

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.26-0.94%
RGENRepligen Corp+0.50+1.26%
ARRYArray Biopharma Inc-0.01-0.11%
PCRXPacira Pharmaceutica...-0.25-0.69%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts